Riskpilot← Back to searchSign inGet full accessClinmax AB
ABActiveOrg 5594405424Non-specialised wholesale of food, beverages and tobacco · NACE 4639Est. 20230 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
0 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | SEK 0 | — |
| Total assets | SEK 25K | — |
| Equity | SEK 25K | — |
| Employees | 0 | — |
Legal name
Clinmax AB
Org number
5594405424
Legal form
Aktiebolag
NACE code
4639 · Non-specialised wholesale of food, beverages and tobacco
Founded
3 juli 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten Styrelsen ska bestå av 2 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Bolaget skall driva hälso- och sjukvård, utredning och rehabilitering samt idka därmed förenlig verksamhet. Bolaget skall även utföra estetiska injektionsbehandlingar, laser samt hud terapi och idka därmed förenlig verksamhet. Bolaget skall även bedriva butiksverksamhet med försäljning av tobak, tidningar, posttjänster samt enklare förtäring och därmed förenlig verksamhet. Bolaget skall bedriva konsultationer, teknisk projektering samt utveckling inom IT. Slutligen skall bolaget äga och förvalta andra företag. Bolaget skall även bedriva restaurangverksamhet samt därmed förenlig verksamhet.
Address
Email
ziadyanes@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | — |
| Staff expenses | — |
| EBITDA | — |
| Depreciation & amort. | — |
| EBIT | — |
| Net financials | — |
| Profit before tax | — |
| Tax | — |
| Net profit | 0 |
| Item | 2024 |
|---|---|
| Total assets | 25 |
| Equity | 25 |
| Long-term debt | — |
| Short-term debt | — |
| Total debt | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20242024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20242024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20242024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20242024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20242024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-03 – 2024-09-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Chairman | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clinmax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ziad Yanes | Board of Directors | 0 companies |
| Mahmoud Aydi | Deputy Board Member | 0 companies |
| Lana Alaydi | Chairman | 0 companies |